Search Medical Condition
Please enter condition
Please choose location

Ponferrada, Spain Clinical Trials

A listing of Ponferrada, Spain clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

Prevalence and Outcome of Acute Hypoxemic Respiratory Failure

The present study is aimed to establish the epidemiological characteristics and clinical outcomes of adult mechanically ventilated patients with acute hypoxemic respiratory failure [defined as a PaO2/FiO2 300 mmHg on positive end-expiratory pressure (PEEP) of 5 cmH2O or more and FiO2 of 0.3 or more] admitted in a network of ...

Phase N/A

0.0 miles

Learn More »

Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency Units

Open, randomized clinical trial to compare emergency pain relief between methoxyflurane and standard of care in patients with trauma and associated pain, treated in Spanish emergency units. Methoxyflurane is a fluorinated ethyl methyl ether, with the chemical name 2:2-dichloro-1:1-difluoroethyl methyl ether. It belongs to the fluorinated hydrocarbon group of volatile ...

Phase

2.27 miles

Learn More »

Spanish Bacteriemia Cohort 2016: Epidemiology Clinical Management and Prognosis Factors

Bacteremia The Hypothesis of the study are the followings: To demonstrate relevant epidemiologic and clinical changes with potentially impact in the management and prognosis of the patients with bacteremia. Since the diagnosis and management is heterogeneous between centers, we could identify a scenario to improve. To identify quality indicators in ...

Phase N/A

2.27 miles

Learn More »

A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment

The purpose is to observe the compliance to a high-calorie, high protein peptide-based nutritional supplement after 3 months in a malnourished population with impaired gastrointestinal tolerance living in nursing homes and as outpatients.

Phase N/A

2.27 miles

Learn More »

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

2.82 miles

Learn More »

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Nemiralisib is being developed as an anti-inflammatory drug for the treatment of inflammatory airways disease. This study is designed to assess the dose response, efficacy, safety, and pharmacokinetics of nemiralisib across a range of doses [up to 750 micrograms (g)] compared with placebo. The study consists of a Screening Period, ...

Phase

2.82 miles

Learn More »